Delivery Order SPE2DB25D3306-SPE2DB25FUCXB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- The Defense Logistics Agency awarded a delivery order valued at $4,402.77 to AmerisourceBergen Drug Corp for the supply of Methotrexate 2.5 mg tablets in unit dose packaging of 20s. This firm fixed price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $373,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. As one of the largest pharmaceutical distributors supporting the Department of Defense supply chain, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply...
- The Defense Logistics Agency Troop Support Medical awarded a $132,100 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be delivered to a facility in Conshohocken, Pennsylvania by September 19, 2023. Amerisourcebergen will serve as the prime contractor to supply the requested prescription drugs to the Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,236 to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. The order was placed under an existing prime vendor contract vehicle to source pharmaceutical products for various Department of Defense medical treatment facilities. Performance will occur at Amerisourcebergen's distribution center in Conshohocken, Pennsylvania, with delivery required between...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,957.04 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 tablets of 2.5 mg Methotrexate. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by December 7, 2023. This delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $199.65 to Amerisourcebergen Drug Corp for the supply of 100 units of 2.5 mg Methotrexate tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania under a one-day period of performance beginning August 1, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts to...
- The Defense Logistics Agency Troop Support Medical awarded a $29,840 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 2.5 mg methotrexate. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide the pharmaceutical products from its facility in Conshohocken, Pennsylvania, with delivery required between July 14-17, 2023. The pricing is firm fixed price. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets at a value of $573.57. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on July 27, 2023. The firm fixed price contract has no set-aside designation and supports the DLA's medical supply procurement programs. As...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,379,519 units of Methotrexate 2.5 mg tablets. The $1,210.26 firm fixed-price delivery order has an ultimate completion date of August 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCXBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $10,409.17. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order and is scheduled for completion by September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition and its extensive portfolio of drug deliveries across multiple therapeutic domains position it as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 9/5/25 |